U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976723) titled 'Nerivio Efficacy by Time of Treatment Onset' on April 24.
Brief Summary: This is a Post-marketing study investigating the impact of treatment time onset with Nerivio on the efficacy of Remote Electrical Neuromodulation (REN) for the acute treatment of migraine.
Efficacy will be evaluated as a change in headache pain severity and functional disability from baseline to 2 hours post-treatment in at least 50% of the treatments, based on the treatment start time from the beginning of the migraine attack.
Study Start Date: May 07
Study Type: INTERVENTIONAL
Condition:
Migraine
Acute Treatment of Migraine
Intervention:
DEVICE: Nerivio...